The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[4-(2-chloro-5-methylpyrimidin-4-yl)phenyl]-N-({4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl}methyl)-2,4-dihydroxybenzamide ID: ALA3730188
PubChem CID: 117967688
Max Phase: Preclinical
Molecular Formula: C30H27ClF2N4O3
Molecular Weight: 565.02
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cnc(Cl)nc1-c1ccc(N(Cc2ccc(CN3CCC(F)(F)C3)cc2)C(=O)c2ccc(O)cc2O)cc1
Standard InChI: InChI=1S/C30H27ClF2N4O3/c1-19-15-34-29(31)35-27(19)22-6-8-23(9-7-22)37(28(40)25-11-10-24(38)14-26(25)39)17-21-4-2-20(3-5-21)16-36-13-12-30(32,33)18-36/h2-11,14-15,38-39H,12-13,16-18H2,1H3
Standard InChI Key: NDZDDEMSENNYBA-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6024 2.6977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4990 0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8964 -0.7553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1931 -1.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1885 -3.0094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8871 -3.7554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5904 -3.0014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -1.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8007 1.4864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0971 0.7319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0919 -0.7681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7903 -1.5136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4939 -0.7591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8824 -5.2561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3875 -1.5257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5799 -6.0002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5728 -7.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8683 -8.2562 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1709 -7.5123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1779 -6.0123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2200 -5.4173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5308 -8.0953 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-10.3802 -3.0265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-11.5877 -3.8947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.1143 -5.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.6143 -5.3077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1607 -3.8779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.3067 -5.1830 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-10.6025 -6.4034 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
3 8 1 0
4 9 1 0
9 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 13 1 0
17 25 1 0
22 26 1 0
25 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 25 1 0
31 32 1 0
28 33 1 0
26 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 34 1 0
36 39 1 0
36 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 565.02Molecular Weight (Monoisotopic): 564.1740AlogP: 6.20#Rotatable Bonds: 7Polar Surface Area: 89.79Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 7.83CX Basic pKa: 5.67CX LogP: 6.32CX LogD: 6.17Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.26Np Likeness Score: -1.03
References 1. (2015) Resorcinol n-aryl amide compounds, for use as pyruvate dehydrogenase kinase inhibitors, 2. Morrell, J A JA and 5 more authors. 2003-12 AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2. [PMID:14641019 ] 3. Meng, Tao T and 10 more authors. 2014-12-11 Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90. [PMID:25383915 ] 4. Moore, Jonathan D and 12 more authors. 2014-12-30 VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells. [PMID:25404640 ] 5. Narayan, Satya S and 7 more authors. 2019-01-01 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. [PMID:30384048 ]